Senior GDP Medicines Inspector, MHRA
Peter is a pharmacist by profession with experience of manufacturing, retail pharmacy and wholesaling. After managing a number of warehouses around the UK he moved to Head Office as Head of RA and QA and was Responsible Person for various companies. He was instrumental identifying the first of the recent counterfeit medicines. Peter worked with the MHRA on the Anti-Counterfeit strategy, ultimately joining the MHRA in early 2013. Peter sits on the Falsified Medicinal Products Stakeholder Group and is involved with a number of the working groups on the implementation of FMD.